Physician profile
Justin Hebert
NPI 1356704308
$5,390.84
in general payments reported to CMS, 2019-2025
14 companies · $595 in 2025
The $595 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $64.42 · 2021: $1,377 · 2022: $599 · 2023: $1,835 · 2024: $921 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018 · Travel and Lodging: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.59 |
| Travel and Lodging | $1,333.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,293.99 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Medtronic, INC. | $642.69 | 2021-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Accurian |
| Abbott Laboratories | $595.43 | 2021-2025 | Eterna |
| Nevro Corp. | $178.24 | 2021-2024 | Senza |
| Nalu Medical, INC. | $177.16 | 2021-2025 | Nalu Neurostimulation System |
| Abbvie INC. | $163.70 | 2021-2025 | |
| Relievant Medsystems, INC. | $143.53 | 2022 | |
| Biotronik Nro, INC. | $68.51 | 2025 | Prospera |
| Globus Medical, INC. | $33.33 | 2025 | Senza |
| Averitas Pharma INC. | $26.82 | 2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $22.05 | 2023 | Xtampza |
| Mml US, INC. | $15.47 | 2023 | Reactiv8 |
| Impel Pharmaceuticals INC. | $15.26 | 2023 | Trudhesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.66 | 2025 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.